Chapter 3: Drug Regulation, Development, Names, and Information

Chapter 3: Drug Regulation, Development, Names, and Information

 

Complete Chapter Questions With Answers

 

Sample Questions Are Posted Below

 

1. A nurse educator is providing a continuing education class on pharmacology. To evaluate the learning of the nurses in the class, the nurse educator asks, “Which of the following is (or are) a generic drug name?”

a.	Acetaminophen
b.	Tylenol
c.	Cipro
d.	Motrin

 

 

ANS:   A

Acetaminophen is the generic name.

Tylenol, Cipro, and Motrin are all trade names.

 

DIF:    Cognitive Level: Comprehension      REF:    p. 20

TOP:    Nursing Process: Evaluation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies

 

2. A researcher working for a pharmaceutical company is providing orientation to a new nurse researcher. The researcher determines that further education is needed when the nurse states that

a.	preclinical testing takes place in animals.
b.	clinical testing phase 1 involves normal volunteers.
c.	clinical testing phase 2 involves normal volunteers.
d.	clinical testing phase 3 involves patients.

 

 

ANS:   C

Clinical testing phase 2 involves patients, not normal volunteers, therefore further education is required.

Preclinical testing does take place in animals, therefore no further education is necessary.

Clinical testing phase 1 does involve normal volunteers, therefore no further education is needed.

Clinical testing phase 3 involves patients, therefore no further education is required.

 

DIF:    Cognitive Level: Comprehension      REF:    p. 17

TOP:    Nursing Process: Evaluation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies

 

3. A nurse is providing discharge teaching about an opiate analgesic for a patient. The nurse correctly tells the patient that the greatest potential for abuse exists with drugs from which schedule?

a.	I
b.	II
c.	III
d.	IV

 

 

ANS:   A

Schedule I drugs have the greatest potential for abuse.

Drugs from schedule II have less potential for abuse.

Drugs from schedule III also have less potential for abuse.

Drugs from schedule IV do not have the greatest potential for abuse.

 

DIF:    Cognitive Level: Comprehension      REF:    p. 15

TOP:    Nursing Process: Implementation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies

 

4. A prescriber orders a drug that is considered “off label.” A patient asks what “off label” means. The nurse correctly explains that “off label” means that a drug is

a.	still being tested in the FDA experimental stages.
b.	FDA approved for one use but is being prescribed for another purpose.
c.	in the “fast-track” FDA approval process to expedite use.
d.	a schedule I drug but may be used as a schedule II drug.

 

 

ANS:   B

The term off label indicates that the drug is approved for one use but may be used for a different purpose.

A drug still being tested in the FDA experimental stages is called an investigational drug.

The term fast track refers to the expeditious nature in which a drug would be channeled for approval by the FDA.

The classification of scheduled drugs has to do with abuse potential, not labeled or unlabeled uses.

 

DIF:    Cognitive Level: Comprehension      REF:    p. 16

TOP:    Nursing Process: Implementation

MSC:   NCLEX Client Needs Category: Physiological Integrity: Pharmacological and Parenteral Therapies